The mission of the Office of Health Promotion Research is to further knowledge and understanding of health promotion and disease prevention through the development of theory-based rigorously controlled research in health education and health promotion.

Our current research is primarily focused on the promotion and surveillance of effective breast cancer screening through the Vermont Breast Cancer Surveillance System. We are one of six core sites of the national Breast Cancer Surveillance Consortium, as well as the PROSPR Research Center funded by the National Cancer Institute to conduct research to improve the cancer screening process.

Our earlier research focused on tobacco control through smoking prevention and smoking cessation, AIDS prevention, diabetes prevention, and reducing alcohol use by youth. These research projects grew out of earlier ones which we have carried out since the early 1980s by emeriti faculty members Roger H. Secker-Walker M.D., John K. Worden, Ph.D., Brian S. Flynn, Sc.D., Berta Geller, Ed.D., and Laura J. Solomon, Ph.D.

UVM COM PostDoc award Hart
digital mammography_186x140
Larner COM and UVM aerial view
  • Gorgeous Neuroscience Meets Student Life
    March 24, 2017 by Sarah Tuff Dunn
    Pioneered by Professor James Hudziak, M.D., Dr. Jim to his students, WE has significantly reduced substance abuse on campus while earning national buzz for its novel and ground-breaking approach to neuroplasticity, mindfulness, and the charismatic mastermind behind the program. No college has tried at this level before.
  • Class of 2017’s Match Day Celebration Featured in Local Media
    March 23, 2017 by Kate Skinas
    The Class of 2017 learned their residency placements at this year’s Match Day that was held at 12:00 pm in the Hoehl Gallery of the Larner College of Medicine on Friday, March 17.
  • Moses’ Study on Fecal Transplant Cure for GIl Disorders Featured in 7Days
    March 23, 2017 by Kate Skins
    Clostridium difficile, commonly known as C. diff, affects nearly half a million Americans a year, and leads to several thousand fatalities, according to the CDC. This infection is difficult to treat, especially among those with an antibiotic-resistant strain, but Peter Moses, M.D., professor of medicine at the Larner College of Medicine and gastroenterologist at the UVM Medical Center, uses fecal microbiota transplantation (FMT) as a solution.